Bob Lutz

Bob Lutz has a long and varied career in the biotechnology and pharmaceutical industry. Bob began their career in 1987 as a Postdoctoral Fellow at the Eleanor Roosevelt Institute. In 1992, they joined ImmunoGen, Inc. as Vice President of Translational Research and Development. In 2015, they became a BioPharma Consultant for Crescendo BioPharma Consulting, providing strategic, tactical, and operational expertise to emerging biotechnology and pharmaceutical companies. In 2016, they joined Iksuda Therapeutics as Chief Scientific Officer and a Scientific Advisory Board Member. Bob also joined Synthis Therapeutics, Inc. as Chief Development Officer and a Board of Director.

Bob Lutz attended the University of New Hampshire from 1977 to 1981, where they earned a BS in Biochemistry. Bob then attended Brandeis University from 1981 to 1987.